Evidence map›Paper›PMID 27810988›Full record

ArticleDiabetes care2017

The Association of Arsenic Exposure and Metabolism With Type 1 and Type 2 Diabetes in Youth: The SEARCH Case-Control Study.

Maria Grau-Pérez, Chin-Chi Kuo, Miranda Spratlen, Kristina A Thayer, Michelle A Mendez, Richard F Hamman, Dana Dabelea, John L Adgate, William C Knowler, Ronny A Bell and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Conserved Molecular Responses to Arsenite Exposure inbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. The role of regulated necrosis in diabetes and its complications.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
  7. Review
  8. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Endocrine Disrupting Chemicals and Type 1 Diabetes.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Anti-diabetic Effect ofIndian journal of clinical biochemistry : IJCB · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 2 countries.

Maria Grau-PérezDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD mgraupe1@jhu.edu anavasa1@jhu.edu.
Chin-Chi KuoDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Miranda SpratlenDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Kristina A ThayerDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC.
Michelle A MendezDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
Richard F HammanDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO.
Dana DabeleaDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO.
John L AdgateDepartment of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado Denver, Aurora, CO.
William C KnowlerDiabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.
Ronny A BellWake Forest School of Medicine, Winston-Salem, NC.
Frederick W MillerNational Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD.
Angela D LieseDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC.
Chongben ZhangDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
Christelle DouilletDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
Zuzana DrobnáDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
Elizabeth J Mayer-DavisDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
Miroslav StybloDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
Ana Navas-AcienDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD mgraupe1@jhu.edu anavasa1@jhu.edu.
University of North Carolina at Chapel Hill · USJohns Hopkins University · USNational Institute of Environmental Health Sciences · USUniversity of Colorado Denver · USChina Medical University Hospital · TWColorado School of Public Health · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNorth Carolina State University · USUniversity of South Carolina · USWake Forest University · US

Funding

Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune DiseaseZIAES101074 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$34.6M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
Traning Program in Environmental Health SciencesT32ES007141 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI Marsha Wills-Karp · 1985 to 2026
$22.2M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Epidemiology of Type 2 Diabetes Mellitus in the Gila River Indian CommunityZIADK069000 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KNOWLER, WILLIAM C · 2009 to 2021
$3.4M
Arsenic Exposure, Genetic Determinants and Diabetes Risk in a Family StudyR01ES021367 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI NAVAS-ACIEN, ANA, VAIDYA, DHANANJAY MADHUKAR · 2012 to 2015
$2.4M
Defining Diabetes in YouthR01DK059184 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HAMMAN, RICHARD F · 2002 to 2007
$2.3M
Arsenic, Epigenetics and Incident Cardiovascular Disease in American IndiansR01ES025216 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI FALLIN, M DANIELE, NAVAS-ACIEN, ANA · 2015 to 2018
$2.2M
NICHD NIH HHS P2C HD050924NIDDK NIH HHS P30 DK056350NIDDK NIH HHS R01 DK059184NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P42 ES010349NIEHS NIH HHS R01 ES021367NIEHS NIH HHS R01 ES025216NIEHS NIH HHS T32 ES007141
6 · The paper itself

Abstract

objectiveLittle is known about arsenic and diabetes in youth. We examined the association of arsenic with type 1 and type 2 diabetes in the SEARCH for Diabetes in Youth Case-Control (SEARCH-CC) study. Because one-carbon metabolism can influence arsenic metabolism, we also evaluated the potential interaction of folate and vitamin B12 with arsenic metabolism on the odds of diabetes. RESEARCH DESIGN AND

methodsSix hundred eighty-eight participants <22 years of age (429 with type 1 diabetes, 85 with type 2 diabetes, and 174 control participants) were evaluated. Arsenic species (inorganic arsenic [iAs], monomethylated arsenic [MMA], dimethylated arsenic [DMA]), and one-carbon metabolism biomarkers (folate and vitamin B12) were measured in plasma. We used the sum of iAs, MMA, and DMA (∑As) and the individual species as biomarkers of arsenic concentrations and the relative proportions of the species over their sum (iAs%, MMA%, DMA%) as biomarkers of arsenic metabolism.

resultsMedian ∑As, iAs%, MMA%, and DMA% were 83.1 ng/L, 63.4%, 10.3%, and 25.2%, respectively. ∑As was not associated with either type of diabetes. The fully adjusted odds ratios (95% CI), rescaled to compare a difference in levels corresponding to the interquartile range of iAs%, MMA%, and DMA%, were 0.68 (0.50-0.91), 1.33 (1.02-1.74), and 1.28 (1.01-1.63), respectively, for type 1 diabetes and 0.82 (0.48-1.39), 1.09 (0.65-1.82), and 1.17 (0.77-1.77), respectively, for type 2 diabetes. In interaction analysis, the odds ratio of type 1 diabetes by MMA% was 1.80 (1.25-2.58) and 0.98 (0.70-1.38) for participants with plasma folate levels above and below the median (P for interaction = 0.02), respectively.

conclusionsLow iAs% versus high MMA% and DMA% was associated with a higher odds of type 1 diabetes, with a potential interaction by folate levels. These data support further research on the role of arsenic metabolism in type 1 diabetes, including the interplay with one-carbon metabolism biomarkers.

Indexed as

AdolescentArsenicBiomarkersCase-Control StudiesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Environmental ExposureFemaleFolic AcidHumansMaleVitamin B 12Young AdultArsenicBiomarkersFolic AcidVitamin B 12

Identifiers

PMID27810988
PMCPMC5180459
OpenAlexW2548826593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.